Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-07-19
2005-07-19
Prats, Francisco (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S017400, C514S018700, C514S002600, C530S326000, C530S329000, C530S330000, C530S331000, C530S343000, C530S344000, C530S300000, C530S316000, C435S068100, C930S040000
Reexamination Certificate
active
06919314
ABSTRACT:
The invention relates to a partial hydrolysate of whey protein which contains bioactive peptides but does not have a bitter flavor. The hydrolysate is carried out using selective enzymes which produce the active peptides and is terminated at a degree of hydrolysis before substantial bitter flavors are created. There are also described novel peptides and a method of reducing systolic blood pressure through the administration of the peptides.
REFERENCES:
patent: 3843621 (1974-10-01), Strachan
patent: 3970520 (1976-07-01), Feldman et al.
patent: 4358464 (1982-11-01), Soehnlen
patent: 4847096 (1989-07-01), Mellqvist et al.
patent: 4918008 (1990-04-01), Gauri
patent: 4981704 (1991-01-01), Thibault
patent: 5039532 (1991-08-01), Jost et al.
patent: 5405637 (1995-04-01), Martinez et al.
patent: 5589357 (1996-12-01), Martinez et al.
patent: 5744179 (1998-04-01), Shimamura et al.
patent: 5780439 (1998-07-01), Mendy et al.
patent: 5837312 (1998-11-01), Cordle et al.
patent: 065663 (1982-12-01), None
patent: 117047 (1984-08-01), None
patent: 0322589 (1989-07-01), None
patent: 0421309 (1991-04-01), None
patent: 474 506 (1991-09-01), None
patent: 799577 (1997-10-01), None
patent: 474506 (1998-05-01), None
patent: 2309154 (1976-11-01), None
patent: GB 996857 (1992-10-01), None
patent: 04-282398 (1992-10-01), None
patent: 04282400 (1992-10-01), None
patent: 05103595 (1993-04-01), None
patent: 06-345664 (1994-12-01), None
patent: 8056568 (1996-03-01), None
patent: 8098656 (1996-04-01), None
patent: 9047229 (1997-02-01), None
patent: 10033115 (1998-02-01), None
patent: WO 9304593 (1993-03-01), None
patent: WO 93/24020 (1993-12-01), None
patent: WO 96/11584 (1996-04-01), None
patent: WO 01/85984 (2001-11-01), None
Abubakar et al (Tohoku Journal of Agricultural Research 47(1-2):1-8 (1996).
Chemical Abstracts 114:82552 (Komura et al), 1990.
Mullally et al., “Angiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proeinase digest of whey proteins.”International Diary Journal, vol. No. 7, (1997), pp. 229-303, XP00953726; Correspondence (Reprint) address, R.J. Fitzgerald, Dep. Of Life Sci., Univ. of Limerick, Limerick, Republic of Ireland; the whole document.
Nakamura Y. Yamamoto N. et al., Antihypertensive effect of peptides derived from casein by an extracellular proteinase form Lactobacillus helveticus CP790.Journal of Diary Science77:917-922 (1994).
Roy, G. “Bitterness: reduction and inhibition.”Trends in Food Science and Technology3:85-91 (1992).
Yamamoto et al. “Antihypertensive peptides derived from food proteins”Biopolymers43:129-134 (1997).
Adler-Nissen J: “Enzymic hydrolysis of food proteins” 1986,Elsevier Applied Science Publishers, London and NY XP002122275 p. 59-62 and p. 94-96.
Bernal and Jelen “Effectiveness of lactose hydrolysis in Cottage cheese Whey for the development of whey drinks”Milchwissenchaft44:222-225 (1989).
Cushman D W & Cheung HS. “Spectrophotometric assay and properties of the angiotensin converting enzyme in rabbit lung”Biochem. Pharmacol. 20:163 7-1648 (1971).
Maubois et al., “Les peptides du lait a activite physiologique III. Peptides du lait a effect cardiovasculaire: activites antithrombotique”Lait71,249:955 (1991).
Masuda et al., “Angiotensin I converting enzyme inhibitory peptides generated from sardine muscle by protease of food industry”Journal of the Japanese Society for Food Science and Technology39(8):678-683 (1992-abstract.
Reed, G. “Enzymes in Food Processing, ” Academic Press, Second Edition, pp. 33-37, Apr. 1975.
Reid Julian Robert
Schlothauer Ralf-Christian
Schollum Linda May
Singh Anne Maria
Knobbe Martens Olson & Bear LLP
New Zealand Dairy Board
Prats Francisco
LandOfFree
Bioactive whey protein hydrolysate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioactive whey protein hydrolysate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioactive whey protein hydrolysate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3426571